NAT-LANTHANUM
Identification of Nat-Lanthanum
| No description |
Google image searchProduct monograph
Active ingredient
lanthanum (lanthanum carbonate dihydrate), 250 MG
DIN: 02498731
Dosage form(s): TABLET (CHEWABLE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 21-JUL-2020
ATC:
- V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V03AE — Drugs for treatment of hyperkalemia and hyperphosphatemia (ATC, ATC/DDD)
- V03AE03 — LANTHANUM CARBONATE (ATC/DDD)
Reference brand drug: Fosrenol
